Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Prothena Corporation PLC - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
PRTA
Nasdaq
8731
https://www.prothena.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Prothena Corporation PLC
Analysts Have Lowered Expectations For Prothena Corporation plc (NASDAQ:PRTA) After Its Latest Results
- May 12th, 2024 12:05 pm
Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
- May 9th, 2024 3:52 pm
Prothena (PRTA) Reports Q1 Loss, Lags Revenue Estimates
- May 8th, 2024 10:10 pm
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
- May 8th, 2024 8:05 pm
We think Prothena Corporation plc's (NASDAQ:PRTA) CEO May Struggle To See Much Of A Pay Rise This Year
- May 8th, 2024 10:23 am
Prothena to Report First Quarter 2024 Financial Results on May 8
- May 1st, 2024 8:05 pm
Earnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline
- Apr 25th, 2024 2:01 pm
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
- Apr 15th, 2024 8:05 pm
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
- Mar 28th, 2024 12:00 pm
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
- Mar 26th, 2024 3:21 pm
Prothena to Participate in Upcoming Healthcare Conferences
- Mar 5th, 2024 9:05 pm
Prothena Appoints David Ford to Newly Created Chief People Officer Position
- Mar 4th, 2024 9:05 pm
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
- Feb 21st, 2024 9:05 pm
Prothena Full Year 2023 Earnings: Beats Expectations
- Feb 17th, 2024 12:45 pm
Prothena (PRTA) Q4 Earnings Miss Estimates on Higher R&D Expense
- Feb 16th, 2024 6:33 pm
Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript
- Feb 16th, 2024 3:33 pm
Prothena Corp PLC (PRTA) Reports 2023 Financial Results and Provides 2024 Outlook
- Feb 15th, 2024 9:48 pm
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
- Feb 15th, 2024 9:05 pm
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
- Feb 8th, 2024 9:05 pm
Arvinas, Inc. (ARVN) Soars 10.0%: Is Further Upside Left in the Stock?
- Feb 2nd, 2024 7:59 am
Scroll